Sign in
4

Changes in Ownership

Cytosorbents Corp Filed Acc 0001104659-25-005358

Director acquired 15,879 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
BATOR MICHAEL G. Director 2025-01-17 Option exercise +15,879 $1.00 $15,879 141,273 D
Derivatives
BATOR MICHAEL G. Director 2025-01-17 Option exercise · Subscription Rights (right to buy) −15,879 0 D
BATOR MICHAEL G. Director 2025-01-17 Other acquisition · Series A Right Warrants +15,879 15,879 D
BATOR MICHAEL G. Director 2025-01-17 Other acquisition · Series B Right Warrants +15,879 15,879 D
Loading xslF345X05/tm254168-5_4seq1.xml…